The Role of Bispecific Antibodies

Bispecific antibodies (BsAbs) are reshaping cancer treatment, offering new possibilities for patients with hematologic malignancies and solid tumors. Bispecific antibodies are engineered proteins that combine two different antibody binding sites, allowing them to target two distinct antigens simultaneously. This unique design enables them to bridge between different immune cells and cancer cells, enhancing the immune response against specific targets. 

The use of bispecific antibodies has a growing role in oncology. At ECHO we remain at the forefront of care, leveraging the newest advancements in cancer treatment. We do so in a community setting, as an independent private practice.